Documente Academic
Documente Profesional
Documente Cultură
Background
Transient synovitis (TS) is the most common cause of acute hip pain in
children aged 3-10 years. The disease causes arthralgia and arthritis
secondary to a transient inflammation of the synovium of the hip.
Pathophysiology
Biopsy reveals only nonspecific inflammation and hypertrophy of the
synovial membrane. Ultrasonography demonstrates an effusion that
causes bulging of the anterior joint capsule. Synovial fluid has increased
proteoglycans.
Frequency
United States
Little data are available regarding the frequency of this illness. However,
excluding infections and trauma, transient synovitis is one of the most
common causes of joint pain in the pediatric age group.
Mortality/Morbidity
The possible etiologic relationship between transient synovitis and LeggCalv-Perthes disease (LCP) is controversial. Although some children with
transient synovitis may develop LCP, whether persistence of increased
intraarticular pressure eventually causes avascular necrosis or whether
patients may have a synovitis that occurs before detection of femoral
head collapse is not fully known. Approximately 1.5% of patients with
transient synovitis develop LCP. Coxa magna, osteoarthritis, or
recurrences may occur.
Sex
Transient synovitis affects boys twice as often as girls.
Age
Transient synovitis most frequently occurs when individuals are aged 3-10
years; however, transient synovitis has been reported in a 3-month-old
infant and in adults. Nonetheless, children outside the typical age group
are unlikely to have transient synovitis. Some teenagers with enthesitisassociated arthritis are initially diagnosed erroneously with toxic synovitis
when they first present with hip pain.
Clinical
History
Hip pain: Unilateral hip or groin pain is the most common report;
however, some patients with transient synovitis (TS) may report
medial thigh or knee pain. Guidelines for chronic hip pain have been
established.1
Physical
Hip
o
o
o
o
o
Knee
o
o
Causes
No definitive cause of transient synovitis is known, although the following
have been suggested:
Differential Diagnoses
Arthritis,
Juvenile
Juvenile
Osteomyelitis
Idiopathic
Rheumatoid
Septic
Arthritis
Arthritis
necrosis
arthritis
arthritis3
tissue
arthralgias
injury
Workup
Laboratory Studies
The following studies may be indicated in transient synovitis (TS):
CBC count: The white blood cell (WBC) count may be slightly
elevated.
Erythrocyte sedimentation rate (ESR)
o
The erythrocyte sedimentation rate (ESR) may be slightly
elevated. One study found that the combination of an ESR
greater than 20 mm/h and/or a temperature greater than
37.5C identified 97% of individuals with septic hip.4
o
Another study by Kocher et al used 4 independent predictors
of septic arthritis to distinguish it from transient synovitis and
the need for further workup.5 They concluded that patients
who were nonweightbearing and had history of fever, an ESR
greater than 40 mm/h, and a WBC count greater than 12,000
cells/mm had a 99.6% high predicted probability of septic
arthritis.
o
Luhmann et al applied these 4 criteria to their patient
population and discovered a 59% predicted probability.6
However, when they applied the 3 criteria of history of fever,
a serum WBC count of greater than 12,000 cells/mm, and a
previous health-care visit, they found a predicted probability
of 71% that the patient had septic arthritis.
C-reactive protein
o
C-reactive protein (CRP) level rises within 6 hours after the
onset of septic arthritis of the hip and peaks at 2 days.7
o
A CRP >2 mg/dL (>20 mg/L) has been found to be an
independent risk factor strongly associated with septic hip
arthritis.8
o
Adding in the CRP as a predictive factor, Jung et al found that
patients with 4 of 5 predictors (body temperature >37 C,
ESR >20 mm/h, CRP >1 mg/dL, WBC >11,000/mL, and an
increased hip joint space of >2 mm) had a high probability of
having septic arthritis and were candidates for further study
by MRI or joint aspiration.9
Urinalysis and culture: Both of these tests should be normal.
Urine glycosaminoglycans: One study found a decreased level of
urine glycosaminoglycans in patients who were diagnosed with
Imaging Studies
o
o
If excess fluid is present or the patient has early Legg-CalvPerthes (LCP) disease, plain radiography may reveal an
increase in the teardrop distance (ie, distance between the
medial acetabulum and ossified part of the femoral head).
Compared with the other side, this distance should be the
same or within 1 mm.
One half to two thirds of patients with transient synovitis may
have an accentuated pericapsular shadow.
In one study, as many as 58% of patients with transient
synovitis had the Waldenstrm sign (ie, lateral displacement
of the femoral epiphyses with surface flattening).
Other studies have reported a positive obturator sign in
established incidents of transient synovitis. This is a
prominent shadow caused by the soft tissues that overlie the
interpelvic aspect of the acetabulum.
Other Tests
Bone scintigraphy
o This test demonstrates mildly elevated uptake; however,
bone scintigraphy may also reveal a transient decrease in
uptake of technetium 99m phosphate.
o Bone scintigraphy does not help the physician differentiate
etiologies.
Procedures
Treatment
Medical Care
Activity
Medication
Nonsteroidal anti-inflammatory drugs (NSAIDs)
These agents have analgesic, antiinflammatory, and antipyretic activities.
They act by inhibiting cyclooxygenase activity, which results in decreased
prostaglandin synthesis. Other mechanisms, such as inhibition of
cyclooxygenase,
thus
inhibiting
formation
of
thus
inhibiting
formation
of
Dosing
Interactions
Contraindications
Precautions
Adult
0.5-1 g/d PO divided bid
Pediatric
10-20 mg/kg/d PO divided bid
Dosing
Interactions
Contraindications
Precautions
Dosing
Interactions
Contraindications
Precautions
Dosing
Interactions
Contraindications
Precautions
cyclooxygenase,
Dosing
Interactions
Contraindications
Precautions
Adult
400 mg PO q4-6h, 600 mg q6h, or 800 mg q8h while symptoms persist;
not to exceed 3.2 g/d
Pediatric
30-40 mg/kg/d PO divided tid/qid
Dosing
Interactions
Contraindications
Precautions
Dosing
Interactions
Contraindications
Precautions
Dosing
Interactions
Contraindications
Precautions
Follow-up
Further Outpatient Care
Complications
Prognosis
Patient Education
Miscellaneous
Medicolegal Pitfalls